Discontinuation report TERAZOSIN-2

Last updated on 2021-08-12 History
Report ID 141500
Drug Identification Number 02237477
Brand name TERAZOSIN-2
Common or Proper name TERAZOSIN 2
Company Name PRO DOC LIMITEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) TERAZOSIN
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-07-31
Actual discontinuation date 2021-07-27
Remaining supply date 2022-10-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-08-12 French Compare
v5 2021-08-12 English Compare
v4 2021-07-27 French Compare
v3 2021-07-27 English Compare
v2 2021-06-25 French Compare
v1 2021-06-25 English Compare

Showing 1 to 6 of 6